Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

United Therapeutic (UTHR)

United Therapeutic (UTHR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,441,644
  • Shares Outstanding, K 44,012
  • Annual Sales, $ 1,449 M
  • Annual Income, $ -104,500 K
  • 60-Month Beta 0.87
  • Price/Sales 3.72
  • Price/Cash Flow N/A
  • Price/Book 1.83

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate 2.32
  • Number of Estimates 3
  • High Estimate 2.44
  • Low Estimate 2.16
  • Prior Year 4.66
  • Growth Rate Est. (year over year) -50.21%

Price Performance

See More
Period Period Low Period High Performance
1-Month
111.34 +11.05%
on 05/14/20
125.94 -1.83%
on 06/03/20
+12.08 (+10.83%)
since 05/05/20
3-Month
75.58 +63.59%
on 03/18/20
125.94 -1.83%
on 06/03/20
+22.42 (+22.15%)
since 03/05/20
52-Week
74.31 +66.38%
on 07/23/19
125.94 -1.83%
on 06/03/20
+40.65 (+48.98%)
since 06/05/19

Most Recent Stories

More News
Liquidia Responds to United Therapeutics Corporation Lawsuit Alleging Infringement of Tyvaso Patents

Liquidia Technologies, Inc. (Nasdaq: LQDA), a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products utilizing its proprietary PRINT(R) technology,...

UTHR : 123.64 (+1.00%)
LQDA : 7.56 (-20.08%)
United Therapeutics Corporation Files Lawsuit Against Liquidia For Infringement Of Tyvaso Patents

and , /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that it has filed a lawsuit in the U.S. District Court for the District of Delaware against Liquidia Technologies,...

UTHR : 123.64 (+1.00%)
United Therapeut Has Returned 31.4% Since SmarTrend Recommendation (UTHR)

SmarTrend identified an Uptrend for United Therapeut (NASDAQ:UTHR) on March 25th, 2020 at $90.09. In approximately 2 months, United Therapeut has returned 31.38% as of today's recent price of $118.35....

UTHR : 123.64 (+1.00%)
Zacks.com featured highlights include: SpartanNash Company, BG Foods, QIAGEN, Regeneron Pharmaceuticals and United Therapeutics

Zacks.com featured highlights include: SpartanNash Company, BG Foods, QIAGEN, Regeneron Pharmaceuticals and United Therapeutics

REGN : 597.00 (-0.26%)
UTHR : 123.64 (+1.00%)
QGEN : 43.83 (-1.19%)
BGS : 24.74 (+2.02%)
SPTN : 21.31 (-2.11%)
5 Stocks Trading Near 52-Week High That Can Scale Higher

Investors target stocks that have been on a bullish run lately. Stocks seeing price strength have a high chance of carrying the momentum forward.

REGN : 597.00 (-0.26%)
UTHR : 123.64 (+1.00%)
QGEN : 43.83 (-1.19%)
BGS : 24.74 (+2.02%)
SPTN : 21.31 (-2.11%)
United Therapeutics Corporation to Present at the Jefferies Virtual Health Care Conference

and , /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that Mr. , Chief Financial Officer and Treasurer of United Therapeutics, will provide an overview and update on the...

UTHR : 123.64 (+1.00%)
Uptrend Call Working As United Therapeut Stock Rises 30.4% (UTHR)

SmarTrend identified an Uptrend for United Therapeut (NASDAQ:UTHR) on March 25th, 2020 at $90.09. In approximately 2 months, United Therapeut has returned 30.41% as of today's recent price of $117.48....

UTHR : 123.64 (+1.00%)
Look for Shares of United Therapeut to Potentially Pullback after Yesterday's 2.99% Rise

United Therapeut (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $120.02 to a high of $123.28. Yesterday, the shares gained 3.0%, which took the trading range above the 3-day high...

UTHR : 123.64 (+1.00%)
SmarTrend Watching for Potential Pullback in Shares of United Therapeut After 2.99% Gain

United Therapeut (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $120.02 to a high of $123.28. Yesterday, the shares gained 3.0%, which took the trading range above the 3-day high...

UTHR : 123.64 (+1.00%)
Zacks.com featured highlights include: SpartanNash, BG Foods, Regeneron, Vipshop and United Therapeutics

Zacks.com featured highlights include: SpartanNash, BG Foods, Regeneron, Vipshop and United Therapeutics

REGN : 597.00 (-0.26%)
UTHR : 123.64 (+1.00%)
BGS : 24.74 (+2.02%)
VIPS : 17.97 (+2.45%)
SPTN : 21.31 (-2.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade UTHR with:

Business Summary

United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening conditions. United Therapeutics (UT) has an overarching commitment to environmental sustainability....

See More

Key Turning Points

2nd Resistance Point 126.56
1st Resistance Point 125.10
Last Price 123.64
1st Support Level 122.11
2nd Support Level 120.59

See More

52-Week High 125.94
Last Price 123.64
Fibonacci 61.8% 106.22
Fibonacci 50% 100.13
Fibonacci 38.2% 94.03
52-Week Low 74.31

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar